ES545486A0 - Procedimiento para la obtencio de compuestos de fosfatidilo - Google Patents

Procedimiento para la obtencio de compuestos de fosfatidilo

Info

Publication number
ES545486A0
ES545486A0 ES545486A ES545486A ES545486A0 ES 545486 A0 ES545486 A0 ES 545486A0 ES 545486 A ES545486 A ES 545486A ES 545486 A ES545486 A ES 545486A ES 545486 A0 ES545486 A0 ES 545486A0
Authority
ES
Spain
Prior art keywords
aliphatic
substituted
etherified
compounds
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES545486A
Other languages
English (en)
Other versions
ES8701186A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES8701186A1 publication Critical patent/ES8701186A1/es
Publication of ES545486A0 publication Critical patent/ES545486A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Tires In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES545486A 1984-07-25 1985-07-23 Procedimiento para la obtencio de compuestos de fosfatidilo Expired ES8701186A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH359884 1984-07-25

Publications (2)

Publication Number Publication Date
ES8701186A1 ES8701186A1 (es) 1986-11-16
ES545486A0 true ES545486A0 (es) 1986-11-16

Family

ID=4259440

Family Applications (1)

Application Number Title Priority Date Filing Date
ES545486A Expired ES8701186A1 (es) 1984-07-25 1985-07-23 Procedimiento para la obtencio de compuestos de fosfatidilo

Country Status (17)

Country Link
US (1) US4788182A (es)
EP (1) EP0169812B1 (es)
JP (1) JPS6143193A (es)
AT (1) ATE45744T1 (es)
AU (1) AU582772B2 (es)
DD (1) DD247680A5 (es)
DE (1) DE3572491D1 (es)
DK (1) DK337485A (es)
ES (1) ES8701186A1 (es)
FI (1) FI78300C (es)
GR (1) GR851825B (es)
HU (1) HU194896B (es)
IL (1) IL75886A (es)
NO (1) NO852953L (es)
NZ (1) NZ212860A (es)
PT (1) PT80851B (es)
ZA (1) ZA855580B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL84387A0 (en) * 1987-11-06 1990-02-09 Rapaport Erich Pharmaceutical compositions containing a substituted phosphatide
IT1230140B (it) * 1989-05-03 1991-10-14 Fidia Spa Derivati della serina, loro processo di preparazione e impiego in terapia umana
DE3929217A1 (de) * 1989-09-02 1991-03-07 Boehringer Mannheim Gmbh Verwendung von phospholipid-derivaten als antivirale arzneimittel und neue phospholipide
US5136032A (en) * 1989-12-07 1992-08-04 Daicel Chemical Industries, Ltd. Method for separating phosphopolyol compounds using a separating agent
US5144045A (en) * 1990-11-13 1992-09-01 American Cyanamid Company Phosphocholine derivative inhibitors of phospholipase A2
DE4229877C2 (de) * 1992-09-04 1994-09-15 Max Delbrueck Centrum Phospho- bzw. Phosphono-(N-acyl)-serine und ihre Herstellung
RU2169734C1 (ru) * 1999-11-30 2001-06-27 Воронежский государственный университет Способ разделения фосфолипидов
CN1294271C (zh) * 2001-02-21 2007-01-10 巴斯福股份公司 制备作为动物饲料添加剂的d-泛酸和/或其盐的方法
DE10109898A1 (de) * 2001-02-21 2002-09-05 Novosom Gmbh Lipide mit veränderlicher Ladung
DE10109897A1 (de) 2001-02-21 2002-11-07 Novosom Ag Fakultativ kationische Liposomen und Verwendung dieser
DE10207177A1 (de) * 2002-02-19 2003-09-04 Novosom Ag Fakultativ kationische Lipide
DE10207178A1 (de) * 2002-02-19 2003-09-04 Novosom Ag Komponenten für die Herstellung amphoterer Liposomen
US7858117B2 (en) 2002-02-21 2010-12-28 Novosom Ag Amphoteric liposomes and their use
JP2007514648A (ja) * 2003-10-24 2007-06-07 エーザイ株式会社 Toll−likereceptor2に関連する疾患及び状態を治療するための化合物及び方法
WO2014067929A1 (en) 2012-10-31 2014-05-08 Akzo Nobel Chemicals International B.V. Phosphated compounds as adhesion promoters
JP5914418B2 (ja) * 2013-06-26 2016-05-11 富士フイルム株式会社 脂質粒子、核酸送達キャリア、核酸送達キャリア製造用組成物、脂質粒子の製造方法及び遺伝子導入方法
CN111808131B (zh) * 2019-04-11 2021-09-17 中国科学院大连化学物理研究所 一对有效抑制Aβ(1-40)聚集和纤维化的手性磷脂分子及其制备方法和应用
CN114369115A (zh) * 2021-12-07 2022-04-19 中国科学院大连化学物理研究所 一对对PrP106-126聚集有抑制作用的手性磷脂

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2447715A (en) * 1947-06-12 1948-08-24 Us Agriculture Esters of diacyl-glycerophosphoric acids
US2436699A (en) * 1947-06-12 1948-02-24 Nasa Nitrogenous diacyl-glycerophosphates
DE1543937C3 (de) * 1966-01-14 1982-12-09 Unilever N.V., 3000 Rotterdam Verwendung modifizierter kephalinhaltiger Phosphatidgemische als Emulgatoren für O/W-Emulsionen und Verfahren zur Herstellung solcher Emulgatoren
US4119714A (en) * 1970-02-27 1978-10-10 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E. V. Glycerin-alkylether-(1)-phosphoric acid-(3)-monocholine esters as enhancers of the natural resistance of the mammalian organism against non-carcinogenic pathogens
US3663235A (en) * 1970-04-13 1972-05-16 Lever Brothers Ltd Process of preparing margarine containing diacyglycerophatide
US4235792A (en) * 1977-04-14 1980-11-25 The Governing Council Of The University Of Toronto Immunological materials
GB2046092B (en) * 1979-03-05 1983-11-02 Toyama Chemical Co Ltd Pharmaceutical composition containing a lysophospholid and a phospholipid
CH641811A5 (en) * 1979-06-18 1984-03-15 Nattermann A & Cie Antilipaemic and antiarteriosclerotic phospholipid derivative
GB2051069B (en) * 1979-06-18 1983-08-24 Nattermann A & Cie Phospholipid derivatives useful in therapy as antilepaemics and antiarteriosclerotics and compositions containing them
US4254115A (en) * 1979-06-18 1981-03-03 A. Nattermann & Cie. Gmbh Phospholipid derivative with an antilipemic and antiarteriosclerotic effect
FI75578C (fi) * 1979-07-25 1988-07-11 Ciba Geigy Ag Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider.
FI803077A7 (fi) * 1979-10-12 1981-04-13 Ciba Geigy Ag Foerfarande foer framstaellning av myramylpeptider
JPS5772914A (en) * 1980-10-22 1982-05-07 Takeda Chem Ind Ltd Antitumor agent
GR78246B (es) * 1981-01-23 1984-09-26 Ciba Geigy Ag
US4534899A (en) * 1981-07-20 1985-08-13 Lipid Specialties, Inc. Synthetic phospholipid compounds
US4426330A (en) * 1981-07-20 1984-01-17 Lipid Specialties, Inc. Synthetic phospholipid compounds
IT1171432B (it) * 1981-08-03 1987-06-10 Fidia Farmaceutici Amidi organiche derivate da lipidi azotati utilizzabili come farmaci
US4607011A (en) * 1982-05-20 1986-08-19 Board Of Trustees, University Of Illinois Accumulation and isolation of N-acylphosphatidylserine
EP0099578B1 (de) * 1982-07-23 1986-11-12 Ciba-Geigy Ag Neue Muramylpeptide und Verfahren zu ihrer Herstellung
US4666893A (en) * 1983-02-15 1987-05-19 St. Thomas Institute Methods of inducing resistance to bacterial and viral infections

Also Published As

Publication number Publication date
ATE45744T1 (de) 1989-09-15
HUT38360A (en) 1986-05-28
PT80851A (de) 1985-08-01
HU194896B (en) 1988-03-28
GR851825B (es) 1985-11-26
FI78300C (fi) 1989-07-10
DE3572491D1 (en) 1989-09-28
EP0169812B1 (de) 1989-08-23
ZA855580B (en) 1986-03-26
DD247680A5 (de) 1987-07-15
AU4537885A (en) 1986-01-30
AU582772B2 (en) 1989-04-13
IL75886A0 (en) 1985-12-31
US4788182A (en) 1988-11-29
PT80851B (pt) 1987-11-30
IL75886A (en) 1989-10-31
DK337485D0 (da) 1985-07-24
DK337485A (da) 1986-01-26
ES8701186A1 (es) 1986-11-16
FI852841A0 (fi) 1985-07-22
EP0169812A1 (de) 1986-01-29
FI852841L (fi) 1986-01-26
NZ212860A (en) 1990-03-27
JPS6143193A (ja) 1986-03-01
NO852953L (no) 1986-01-27
FI78300B (fi) 1989-03-31

Similar Documents

Publication Publication Date Title
AU582772B2 (en) Phosphatidyl compounds, processes for their manufacture, and their use
ES529091A0 (es) Procedimiento para la obtencion de lipopeptidos
DE3687288D1 (de) Chinuclidinderivate.
ES8606394A1 (es) Procedimiento para la obtencion de tetrapeptidos sustituidos
ES8706622A1 (es) Procedimiento para preparar alfa-aminoacidos sustituidos
PT81045B (pt) Processo para a preparacao de novos derivados do nucleosido e da purina 8-substituidos, e de composicoes farmaceuticas contendo-os
ES554634A0 (es) Procedimiento para preparar 2(1h)-piridonas
FI871637A0 (fi) Foerfarande foer framstaellning av 1,5-benzotiazepinderivat.
DK640687D0 (da) Allylmercaptoacetylsydnoniminer, deres fremstilling og anvendelse
DK392686D0 (da) Kulsyremonoesterafledte n- og/eller o-acylater af desferrioxamin b og salte deraf
DK247389A (da) Substituerede 3-aminosydnoniminer eller farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
ES8504180A1 (es) Procedimiento para preparar nuevos derivados de piperidina
FI850215L (fi) 3-alkoxy-2-(n-pyrrolidino)-n-pyridyl- n-furyl(eller tienyl)-metylpropylaminer.
ES2038389T3 (es) Procedimiento para la obtencion de 3-aminosidnoniminas substituidas farmacologicamente activas.
EP0331756A4 (en) Agents for prophylaxis and treatment of thrombopenia
FI870057A0 (fi) Nya tyroninderivat.
ES8504253A1 (es) Un procedimiento para la preparacion de a53868 factor a
DK507186D0 (da) Heterocycliske aminoforbindelser
ES8706722A1 (es) Procedimiento para preparar derivados de aminoacidos